Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinically aligned rationale generation for glaucoma subtype classification via a knowledge-distilled language model.

medRxiv : the preprint server for health sciences·2026
Same author

Spatial Decomposition of Longitudinal RNFL Maps Reveals Distinct Modes of Glaucomatous Progression With Structure-Function and Genetic Signatures.

Investigative ophthalmology & visual science·2026
Same author

Plasma soluble triggering receptor expressed on myeloid cells 2 levels and clinical outcomes in acute decompensated heart failure: A retrospective cohort study.

The Journal of international medical research·2026
Same author

Atlas of Quality of Life in Binocular Visual Field Loss: A Comprehensive Study.

medRxiv : the preprint server for health sciences·2026
Same author

Deep Learning Prediction of Personalized Peripapillary Retinal Nerve Fiber Layer Thickness Norms from Fundus Images in Glaucoma.

medRxiv : the preprint server for health sciences·2026
Same author

Breeding and Molecular Characterization of Insect-Resistant Transgenic Cotton.

Plants (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jul 4, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Sparse-Observation Multi-Horizon Glaucoma Progression Forecasting with Biologically Constrained Temporal Consistency:

Nazlee Zebardast1, Mousa Moradi1, Jerry Cao-Xue2

  • 1Harvard Ophthalmology AI Lab, Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, United States.

Research Square
|July 3, 2026
PubMed
Summary

Forecasting glaucoma progression from limited data is now possible with a new framework. This model predicts long-term outcomes using only two visits, improving accuracy and risk stratification for irreversible diseases.

Keywords:
Glaucoma progressionMulti-horizonTemporal consistencyVFTDcpRNFL

Related Experiment Videos

Last Updated: Jul 4, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Area of Science:

  • Ophthalmology
  • Medical Image Analysis
  • Artificial Intelligence in Medicine

Background:

  • Glaucoma progression forecasting is challenging with sparse longitudinal data due to model limitations.
  • Existing models often require dense, multi-year data and lack biological constraint integration.
  • Irreversible disease progression necessitates models that respect biological constraints.

Purpose of the Study:

  • To develop a novel sparse-observation framework for predicting multi-horizon glaucoma progression outcomes.
  • To incorporate biological constraints, specifically monotonic risk ordering, into a forecasting model.
  • To enable accurate and calibrated long-horizon risk prediction using limited patient visit data.

Main Methods:

  • Introduced a sparse-observation framework utilizing only two patient visits.
  • Developed a Temporally Consistent Multi-Horizon (TCMH) loss function to enforce monotonic risk ordering.
  • Integrated circumpapillary retinal nerve fiber layer (cpRNFL) images, visual field total deviation (VFTD) maps, and clinical covariates using a ConvNeXt architecture.

Main Results:

  • Achieved high performance in two-, three-, and four-year glaucoma progression forecasting (AUROC 0.968, accuracy 0.947).
  • Demonstrated improved calibration (10.2% better than baseline) and minimal demographic disparity (0.0163 max).
  • Outperformed specialist graders in specificity (0.98 vs. 0.57-0.73) on held-out data, enabling efficient risk stratification.

Conclusions:

  • Sparse-observation temporally consistent forecasting is a viable paradigm for calibrated long-horizon risk prediction in progressive diseases.
  • The developed framework accurately predicts glaucoma progression using limited data, respecting disease biology.
  • This approach facilitates automated risk stratification, optimizing clinical review for uncertain cases.